Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FGAYB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,807
Award facts
- Contract value 100% obligated
- $15,807.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,807.30 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026.
This delivery order represents a typical transaction within AmerisourceBergen's extensive portfolio of federal pharmaceutical supply agreements with the Defense Logistics Agency and its Medical Supply Chain. Eliquis, an anticoagulant medication, supports military and veteran healthcare systems as part of the company's broad offerings spanning brand-name and generic drugs, specialty medications, vaccines, and medical supplies across multiple therapeutic domains. The contract demonstrates the contractor's established capability to meet federal procurement requirements through competitive procurement processes and its role as a primary pharmaceutical vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FGAYB?
SPE2DB25FGAYB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FGAYB worth?
The government has obligated $15,807 on SPE2DB25FGAYB.
Is contract SPE2DB25FGAYB an order under another contract?
Yes. SPE2DB25FGAYB is a delivery order under SPE2DB24D3015, an indefinite delivery contract.
Was contract SPE2DB25FGAYB competed?
The extent of competition for SPE2DB25FGAYB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award